Now Available for Public Comment: Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

Mapatumumab, Cisplatin and Radiotherapy for Advanced Cervical Cancer

This study is ongoing, but not recruiting participants.
Sponsor:
Collaborator:
Human Genome Sciences Inc.
Information provided by (Responsible Party):
A.K.L. Reyners, University Medical Centre Groningen
ClinicalTrials.gov Identifier:
NCT01088347
First received: March 10, 2010
Last updated: June 2, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is ongoing, but not recruiting participants.
  Estimated Study Completion Date: December 2014
  Primary Completion Date: March 2014 (Final data collection date for primary outcome measure)